The research update desk
Peptide research updates, without the hype.
We cover real regulatory decisions, trial milestones, major publications, and safety alerts—then explain what actually changed.
All research briefs
FDA & regulatory
Clinical trials
Safety alerts
FDA & regulatory
FDA approves tirzepatide for obstructive sleep apnea in adults with obesity
What the Zepbound approval covers, what supported it, and what it does not mean.
Clinical trials
Retatrutide outcomes program advances through Phase 3
What large ongoing trials are designed to answer—and why retatrutide remains investigational.
Our update filter
No rumor roundups. No speculative pipelines. Every update needs a verifiable milestone and a clear answer to “what changed?”